TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Valvular heart disease in pregnancy

Key Statistics

  • 0–3% — Maternal mortality, mitral stenosis
  • 58% vs 79% — Event-free pregnancy: Mechanical vs bioprosthetic valve (ROPAC)
  • 9% — Maternal death, UKOSS mechanical valve cohort (n=58)

Don't-miss facts

  1. Regurgitant > stenotic; right-sided > left-sided lesions better tolerated in pregnancy

  2. Severe mitral stenosis (valve area <1.0 cm²) and severe symptomatic aortic stenosis = mWHO Class IV – pregnancy contraindicated

  3. ROPAC: mechanical valve 58% vs bioprosthesis 79% event-free pregnancy

  4. LMWH peak anti-Xa target 0.8–1.2 IU/ml; doses >50% higher than standard VTE dosing

  5. Warfarin embryopathy risk markedly ↑ above 5 mg/day dose; highest risk window 6–12 weeks

  6. UKOSS: mechanical valve pregnancies – 9% maternal death, 43% adverse fetal outcome

  7. Neuraxial block: 24h after last LMWH dose; INR <1.5 for warfarin

  8. Warfarin within 2 weeks + emergency delivery → caesarean recommended (neonatal ICH risk)

Anticoagulation strategies at a glance

VKA throughout, LMWH ~2wk pre-delivery LMWH 1st trimester / VKA 2nd–3rd LMWH throughout pregnancy

Abbreviation Key

  • mWHO — modified World Health Organization classification of
  • INR — international normalised ratio maternal cardiovascular risk
  • ROPAC — Registry of Pregnancy and Cardiac Disease
  • NYHA — New York Heart Association functional classification
  • UKOSS — UK Obstetric Surveillance System
  • FGR — fetal growth restriction
  • ESC — European Society of Cardiology
  • LMWH — low-molecular-weight heparin
  • LARC — long-acting reversible contraceptive
  • VKA — vitamin K antagonist
  • CSE — combined spinal–epidural
  • UFH — unfractionated heparin
  • LVEF — left ventricular ejection fraction
  • TEC — thromboembolic complication
  • NT-proBNP — N-terminal pro b-type natriuretic peptide

Source: Timmons P, Partridge G, McKelvey A, Lyall H, Morosan M, Freeman L. Valvular heart disease in pregnancy. The Obstetrician & Gynaecologist 2023;25:19–27. doi:10.1111/tog.12857

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free